EGFR and KRAS mutations in the non-tumoral lung. Prognosis in patients with adenocarcinoma

5Citations
Citations of this article
11Readers
Mendeley users who have this article in their library.

Abstract

Tumor recurrence is frequent and survival rates remain extremely low in lung adenocarcinoma (ADC). We hypothesize that carcinogenic factors will promote loco-regional modifications not only in the future tumor, but throughout the exposed lung. Objective: To analyze whether the most prevalent mutations observed in ADC can also be observed in the non-neoplastic lung tissue, as well as the short-term prognosis implications of this finding. Methods: Non-tumoral lung parenchyma specimens obtained during surgery from 47 patients with EGFR and/or KRAS abnormalities in their ADC tumors underwent similar genomic testing. Short-term outcomes were also recorded. Results: The same mutations were present in the tumor and the histologically normal tissue in 21.3% of patients (SM group). Although local recurrences were similar in both groups, distant metastases were more frequent in the former (60 vs. 5.4%, p < 0.001). Moreover, SM patients showed lower time-to-progression (8.5 vs. 11.7 months, p < 0.001) and disease-free survival (8.5 vs. 11.2 months, p < 0.001). COX regression showed a higher risk of progression or death (DFS) in the SM group (HR 5.94, p < 0.01]. Similar results were observed when adjusting for potential confounding variables. Conclusions: These results confirm that genetic changes are present in the apparently normal lung in many ADC patients, and this finding has prognostic implications.

References Powered by Scopus

Global cancer statistics

31579Citations
N/AReaders
Get full text

Cancer statistics, 2016

23619Citations
N/AReaders
Get full text

Comprehensive molecular profiling of lung adenocarcinoma: The cancer genome atlas research network

4301Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Clinicopathological and prognostic values of ErbB receptor family amplification in primary osteosarcoma

8Citations
N/AReaders
Get full text

Long-Term Recurrence of Completely Resected NSCLC

7Citations
N/AReaders
Get full text

Bronchiolar adenomas (BA) - A detailed radio-pathologic analysis of six cases and review of literature

3Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Chalela, R., Bellosillo, B., Curull, V., Longarón, R., Pascual-Guardia, S., Badenes-Bonet, D., … Gea, J. (2019). EGFR and KRAS mutations in the non-tumoral lung. Prognosis in patients with adenocarcinoma. Journal of Clinical Medicine, 8(4). https://doi.org/10.3390/jcm8040529

Readers over time

‘18‘19‘20‘21‘23‘2402468

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 4

100%

Readers' Discipline

Tooltip

Medicine and Dentistry 5

56%

Biochemistry, Genetics and Molecular Bi... 2

22%

Agricultural and Biological Sciences 1

11%

Engineering 1

11%

Article Metrics

Tooltip
Mentions
Blog Mentions: 1
Social Media
Shares, Likes & Comments: 107

Save time finding and organizing research with Mendeley

Sign up for free
0